Why the study?
What is the prevalence of patient-reported statin side-effects among hospitalized cardiac patients?
What is the prevalence of patient-reported statin side-effects among hospitalized cardiac patients?
A high proportion (63.5%) of hospitalized cardiac patients in this Iranian sample reported experiencing side-effects from statins, highlighting the need for clinician awareness.
Answers are grounded in this paper and cite their sources.
High reported statin side-effects merit clinician awareness in cardiac inpatients; cross-sectional data leaves open true prevalence and causality.
We aim to study the prevalence of the side-effects of statins among Iranians patients admitted to a cardiac-specialized hospital and had taken statins prior to hospitalization. Data was collected between September 2007 and March 2008 and 200 patients were enrolled. A questionnaire was completed using the patients' records and by interviewing the patients. The mean age of the participants was 61.5 (SD 12.3) years and 63% were males. The most commonly used statins was atrovastatin (99% of the patients). In all, 63.5% of the participants reported experiencing side-effects due to statins. The reported side-effects were respiratory (18.5%), headache (16.5%), rash (0.5%) and allergic reactions (5%); 9.5% reported (4%) and gastrointestinal effect muscle-related side-effects such as myalgia. Although, the clinical benefits outweigh the small risk of liver failure and myopathy, clinicians should be aware of the side-effects of statins.
No takes yet. Share an insight, caveat, or question.
Mashayekhi et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: